Federation Des Caisses Desjardins Du Quebec Takeda Pharmaceutical CO LTD Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.4 Billion
Q4 2024

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 8,112 shares of TAK stock, worth $112,756. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,112

Previous 8,112 -0.0%

Holding current value

$112,756

Previous $115,000 6.96%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.89 - $15.04 $112,675 - $122,004	8,112 New	8,112 $113 Million
Q3 2023 Aug 14, 2024	BUY	$15.03 - $16.32 $151,322 - $164,309	10,068 Added 327.1%	13,146 $203 Million
Q2 2023 Aug 14, 2024	SELL	$15.57 - $17.11 $23,744 - $26,092	-1,525 Reduced 33.13%	3,078 $48.4 Million
Q1 2023 Aug 14, 2024	BUY	$15.28 - $16.48 $27,504 - $29,664	1,800 Added 64.22%	4,603 $75.9 Million
Q4 2022 Aug 14, 2024	SELL	$12.42 - $15.62 $1,366 - $1,718	-110 Reduced 3.78%	2,803 $43.7 Million
Q2 2022 Aug 14, 2024	SELL	$13.12 - $15.03 $1,705 - $1,953	-130 Reduced 4.27%	2,913 $40.9 Million
Q1 2022 Aug 14, 2024	SELL	$13.54 - $15.35 $68,634 - $77,809	-5,069 Reduced 62.49%	3,043 $43.6 Million
Q2 2021 Aug 30, 2024	SELL	$16.55 - $18.64 $85,712 - $96,536	-5,179 Reduced 63.84%	2,933 $49.4 Million
Q4 2020 Aug 30, 2024	BUY	$15.39 - $18.97 $9,234 - $11,382	600 Added 25.72%	2,933 $53.4 Million
Q1 2020 Aug 30, 2024	SELL	$13.02 - $20.31 $3,268 - $5,097	-251 Reduced 9.71%	2,333 $35.4 Million
Q4 2019 Aug 30, 2024	SELL	$16.88 - $20.83 $1,097 - $1,353	-65 Reduced 2.45%	2,584 $51 Million
Q1 2019 Aug 30, 2024	SELL	$16.7 - $21.52 $91,232 - $117,563	-5,463 Reduced 67.34%	2,649 $54 Million

Others Institutions Holding TAK

# of Institutions

338

Shares Held

68.6M

Call Options Held

1.72M

Put Options Held

178K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Takeda Pharmaceutical CO LTD Transaction History